Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9007589rdf:typepubmed:Citationlld:pubmed
pubmed-article:9007589lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9007589lifeskim:mentionsumls-concept:C0153252lld:lifeskim
pubmed-article:9007589lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:9007589lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:9007589lifeskim:mentionsumls-concept:C0002679lld:lifeskim
pubmed-article:9007589lifeskim:mentionsumls-concept:C0016277lld:lifeskim
pubmed-article:9007589lifeskim:mentionsumls-concept:C0085559lld:lifeskim
pubmed-article:9007589lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:9007589pubmed:issue6lld:pubmed
pubmed-article:9007589pubmed:dateCreated1997-3-28lld:pubmed
pubmed-article:9007589pubmed:abstractTextIn this prospective, randomized study fluconazole and amphotericin B/5-flucytosine were compared in the treatment of systemic candidiasis. Seventy-two non-neutropenic intensive care patients with systemic Candida infections were enrolled. Thirty-six patients were randomly assigned to receive fluconazole (400 mg on the first day then 200 mg) and 36 were randomized to amphotericin B/5-flucytosine (1.0-1.5 mg/kg body weight every other day and 3 x 2.5 g flucytosine/day) for 14 days following the diagnosis. There was no statistically significant difference in clinical outcome in regard to the treatment of pneumonia and sepsis: 18/28 of the patients were treated successfully with fluconazole and 17/27 with amphotericin B/5-flucytosine. For the treatment of peritonitis, however, amphotericin B/5-flucytosine was more effective than fluconazole (55% vs. 25%). Furthermore, amphotericin B/5-flucytosine was found to be superior to fluconazole with regard to pathogen eradication (86% vs. 50%). Fluconazole was associated with less toxicity than amphotericin B/5-flucytosine.lld:pubmed
pubmed-article:9007589pubmed:languageenglld:pubmed
pubmed-article:9007589pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9007589pubmed:citationSubsetIMlld:pubmed
pubmed-article:9007589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9007589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9007589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9007589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9007589pubmed:statusMEDLINElld:pubmed
pubmed-article:9007589pubmed:issn0300-8126lld:pubmed
pubmed-article:9007589pubmed:authorpubmed-author:EmmerlingPPlld:pubmed
pubmed-article:9007589pubmed:authorpubmed-author:KoppAAlld:pubmed
pubmed-article:9007589pubmed:authorpubmed-author:Abele-HornMMlld:pubmed
pubmed-article:9007589pubmed:authorpubmed-author:DauberAAlld:pubmed
pubmed-article:9007589pubmed:authorpubmed-author:OhlyAAlld:pubmed
pubmed-article:9007589pubmed:authorpubmed-author:SternbergUUlld:pubmed
pubmed-article:9007589pubmed:authorpubmed-author:RusswurmWWlld:pubmed
pubmed-article:9007589pubmed:authorpubmed-author:BüchingerWWlld:pubmed
pubmed-article:9007589pubmed:authorpubmed-author:NagengastOOlld:pubmed
pubmed-article:9007589pubmed:issnTypePrintlld:pubmed
pubmed-article:9007589pubmed:volume24lld:pubmed
pubmed-article:9007589pubmed:ownerNLMlld:pubmed
pubmed-article:9007589pubmed:authorsCompleteYlld:pubmed
pubmed-article:9007589pubmed:pagination426-32lld:pubmed
pubmed-article:9007589pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:meshHeadingpubmed-meshheading:9007589-...lld:pubmed
pubmed-article:9007589pubmed:articleTitleA randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients.lld:pubmed
pubmed-article:9007589pubmed:affiliationMax-von-Pettenkofer Institut, München, Germany.lld:pubmed
pubmed-article:9007589pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9007589pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:9007589pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9007589pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:9007589pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9007589lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9007589lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9007589lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9007589lld:pubmed